Role of hCG in vasculogenic mimicry in OVCAR-3 ovarian cancer cell line

International Journal of Gynecological Cancer

Volumn 21, Issue 8, 2011, Pages 1366-1374

  Su, Min ^a,b   Wei, Wei ^a   Xu, Xiangxiang ^a   Wang, Xiaoying ^a   Chen, Caoyi ^a   Su, Li ^a   Zhang, Yuquan ^a  

^a NANTONG UNIVERSITY   (China)

^b SUZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

HCG; HIF 1 ; Hypoxia; Ovarian cancer; Vasculogenic mimicry

Indexed keywords

BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; CHORIONIC GONADOTROPIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NEUTRALIZING ANTIBODY; SMALL INTERFERING RNA; VASCULOTROPIN; HIF1A PROTEIN, HUMAN;

ANTIBODY SPECIFICITY; ARTICLE; CANCER CELL CULTURE; CELL HYPOXIA; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MICROSCOPY; MOLECULAR MIMICRY; OVARY CANCER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; TUMOR MICROENVIRONMENT; VASCULOGENIC MIMICRY; WESTERN BLOTTING; ANOXIA; CELL SHAPE; FEMALE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); OVARY TUMOR; PHYSIOLOGY; TUMOR CELL LINE; VASCULARIZATION;

ANOXIA; CELL LINE, TUMOR; CELL SHAPE; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; RNA, SMALL INTERFERING;

EID: 84863244200     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31822c7529     Document Type: Article

References (24)

1. Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999;155:739-752. (Pubitemid 29426820)
2. Yao LQ, Feng YJ, Ding JX, et al. Differentiation of vascular endothelial cells-like derived from epithelial ovarian cancer cells induced by hypoxia. Int J Oncol. 2007;30:1069-1075.
3. Jean-Claude L, Danielle P, Elodie R, et al. Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro. Cancer Res. 2009;69:802-809.
4. Scavelli C, Nico B, Cirulli T, et al. Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene. 2008;27:663-674. (Pubitemid 351158901)
5. Guzman G, Cotler SJ, Lin AY, et al. A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma. Arch Pathol Lab Med. 2007;131:1776-1781. (Pubitemid 350294576)
6. Clemente MPA, Illera JC, Pena L. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer. Vet Pathol. 2009;47:265-274.
7. Qu B, Guo L, Ma J, et al. Antiangiogenesis therapy might have the unintended effect of promoting tumor metastasis by increasing an alternative circulatory system. Med Hypotheses. 2010;74:360-361.
8. Dome B, Hendrix JC, Paku S, et al. Alternative vascularization mechanisms in cancer pathology and therapeutic implications. Am J Pathol. 2007;170:1-15. (Pubitemid 47339184)
9. Michel RM, Aguilar JL, Arrieta O. Human chorionic gonadotropin as an angiogenic factor in breast cancer during pregnancy. Med Hypotheses. 2007;68:1035-1040. (Pubitemid 46274042)
10. Phan B, Rakenius A, Pietrowski D, et al. HCG-dependent regulation of angiogenic factors in human granulosa lutein cells. Mol Reprod Dev. 2006;73:878-884. (Pubitemid 43825293)
11. Pietrowski D, Wiehle P, Sator M, et al. Regulation of the angiopoietin-2 gene by hCG in ovarian cancer cell line OVCAR-3. Horm Metab Res. 2010;42:328-333.
12. Muller CY, Cole LA. The quagmire of hCG and hCG testing in gynecologic oncology. Gynecol Oncol. 2009;112:663-672.
13. Lempiainen A, Stenman UH, Blomqvist C, et al. Free A-subunit of human chorionic gonadotropin in serum is a diagnostically sensitive marker of seminomatous testicular cancer. Clin Chem. 2008;54:1840-1843.
14. Iles RK, Delves PJ, Butler SA. Does hCG or hCG play a role in cancer cell biology? Mol Cell Endocrinol. 2010;329:62-70.
15. Daniel KD, Kim GY, Vassiliou CC, et al. Multi-reservoir device for detecting a soluble cancer biomarker. Lab Chip. 2007;7:1288-1293. (Pubitemid 47482974)
16. Jankowska AG, Andrusiewicz M, Fischer N, et al. Expression of hCG and GnRHs and their receptors in endometrial carcinoma and hyperplasia. Int J Gynecol Cancer. 2010;20:92-101.
17. Szajnik M, Nowak-Markwitz E, Szczepanski MJ, et al. Assessment of expression of luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptor (LH/hCGR) and hCG protein in ovarian cancer tissues. Ginekol Pol. 2007;78:939-943.
18. Krah X, Klose E, Atanassov G, et al. Urothelium cancer with trophoblastic differentiation. Urologe A. 2006;45:81-84.
19. Tang BZ, Qu Y, Zhao FY, et al. In vitro effects of hypoxia-inducible factor 1[alpha] on the biological characteristics of the SiHa uterine cervix cancer cell line. Int J Gynecol Cancer. 2009;19:898-904.
20. Su M, Yao LQ, Feng YJ, et al. Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo. Int J Gynecol Cancer. 2008;18:476-486. (Pubitemid 351668302)
21. Berndt S, Perrier HS, Blacher S, et al. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J. 2006;20:2189-2198.
22. Herr D, Keck C, Tempfer C, et al. Chorionic gonadotropin regulates the transcript level of VHL, p53, and HIF-2alpha human granulosa lutein cells. Mol Reprod Dev. 2004;69:397-401. (Pubitemid 39463847)
23. Van Den Driesche1 S, Myers M, Gay E, et al. hCG up-regulates hypoxia inducible factor-1 alpha in luteinized granulosa cells: implications for the hormonal regulation of vascular endothelial growth factor A in the human corpus luteum. Mol Hum Reprod. 2008;14:455-464.
24. Meng XL, Owen MR, Chan WY. Human chorionic gonadotropin induces neuronal differentiation of PC12 Cells through activation of stably expressed lutropin/choriogonadotropin receptor. Endocrinology. 2007;148:5865-5873.